- Home
- SPRY vs BLFS Comparison
SPRY vs BLFS Comparison
Compare SPRY & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- BLFS
- Stock Information
- Founded
- SPRY 2015
- BLFS 1987
- Country
- SPRY United States
- BLFS United States
- Employees
- SPRY N/A
- BLFS N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- BLFS Medical/Dental Instruments
- Sector
- SPRY Health Care
- BLFS Health Care
- Exchange
- SPRY Nasdaq
- BLFS Nasdaq
- Market Cap
- SPRY 1.1B
- BLFS 1.3B
- IPO Year
- SPRY N/A
- BLFS 1989
- Fundamental
- Price
- SPRY $9.59
- BLFS $26.95
- Analyst Decision
- SPRY Strong Buy
- BLFS Strong Buy
- Analyst Count
- SPRY 4
- BLFS 4
- Target Price
- SPRY $31.25
- BLFS $31.50
- AVG Volume (30 Days)
- SPRY 2.5M
- BLFS 408.2K
- Earning Date
- SPRY 11-10-2025
- BLFS 11-06-2025
- Dividend Yield
- SPRY N/A
- BLFS N/A
- EPS Growth
- SPRY N/A
- BLFS N/A
- EPS
- SPRY N/A
- BLFS N/A
- Revenue
- SPRY $142,772,000.00
- BLFS $100,144,000.00
- Revenue This Year
- SPRY N/A
- BLFS $25.65
- Revenue Next Year
- SPRY $193.13
- BLFS $14.81
- P/E Ratio
- SPRY N/A
- BLFS N/A
- Revenue Growth
- SPRY 5459.66
- BLFS 87.53
- 52 Week Low
- SPRY $6.66
- BLFS $19.10
- 52 Week High
- SPRY $18.90
- BLFS $29.62
- Technical
- Relative Strength Index (RSI)
- SPRY 57.78
- BLFS 55.06
- Support Level
- SPRY $6.66
- BLFS $23.57
- Resistance Level
- SPRY $7.40
- BLFS $24.88
- Average True Range (ATR)
- SPRY 0.80
- BLFS 1.06
- MACD
- SPRY 0.21
- BLFS 0.17
- Stochastic Oscillator
- SPRY 78.83
- BLFS 90.60
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.